Currently showing only Plant & Animal Breeding Resources
Page 7 of 7

Organic agriculture requires process rather than product evaluation of novel breeding techniques

Publication date: 09/02/2007

In organic agriculture the use of genetically modified organisms (GMOs) is banned.

Recently, two novel breeding techniques have been developed, i.e., cisgenesis and reverse breeding, both of which are based on gene technology but should raise less moral concerns from the public. Whether the products of these breeding processes are classified as GMOs depends on the interpretation of the relevant EU regulations.

In cisgenic plants, the genes introduced through genetic modification are from a crossable donor plant so that the source of the genes is considered to be of the same nature. In reverse breeding, the recombinant genes, essential to the breeding process, are no longer present in the product resulting from the entire breeding process, and thus the product as such is not transgenic. Should varieties obtained through cisgenesis or reverse breeding be allowed in organic agriculture?

The answer to this question depends on whether the product or the process of breeding is taken into account. Assessment based on the product implies a choice of an ethical approach that only considers the extrinsic consequences of human action by making a risk-benefit analysis. It neglects so-called intrinsic, ethical arguments related to the applied technology (the process] itself. The organic movement uses the intrinsic argument of ‘unnaturalness’ against genetic engineering. We therefore conclude that products of cisgenesis and reverse breeding should be subject to the current GMO-regulations in organic agriculture and should thus be banned from organic agriculture.

Resource type: Adobe Acrobat (.pdf)

Foom farm to fork: the regulatory status of non-GMO plant innovations under current EU law

In April 2017, the Scientific Advice Mechanism (‘SAM’)presented its explanatory note on ‘New Techniques in Agricultural Biotechnology’ to the European Commission (‘the SAM Note’). The SAM Note provides a detailed description of the nature and characteristics of so-called‘plant breeding innovations’ or ‘new breeding techniques’(‘NBTs’), and how they are similar to or different from conventional breeding techniques (‘CBT’, such as crossing and selection, or mutation breeding) and established techniques of genetic modification(‘GM’, such as the use of recombinant nucleic acids).

According to the SAM Note, the term ‘NBTs’ refers to a wide range of new breeding methods, some of which are substantially different from established transgenic approaches in their way of introducing traits to an organism.Whereas some NBTs amount to a refinement of CBT and integrate genetic material that is derived from a sexually compatible species, some nevertheless are used in combination with established GM techniques. Some NBTs result in organisms that contain only point mutations and are practically indistinguishable from varieties bred through CBT. The NBTs that have attracted most attention in recent years (and are, presumably also for that reason, currently subject to a preliminary reference to the Court of Justice of the EU or ‘CJEU’) are the so-called genome editing techniques.The present article focuses specifically on those genome editing techniques

Resource type: Adobe Acrobat (.pdf)